Biotech · Private company · Camden, DE, US

Vasarya Therapeutics, Inc.

Track this companyFree. Adds Vasarya Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary FibrosisFiscal year 2026 · $1.1MNIH RePORTER 5R44HL170936-03 · fetched Nov 12, 2026
Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary FibrosisFiscal year 2025 · $1.1MNIH RePORTER 4R44HL170936-02 · fetched Nov 12, 2026
Targeting a disease-specific conformation of fibronectin as a novel approach for liver fibrosis treatmentFiscal year 2024 · $295.9KNIH RePORTER 1R41DK138519-01A1 · fetched Nov 12, 2026
Translating a Novel Therapeutic Approach to the Treatment for Idiopathic Pulmonary FibrosisFiscal year 2024 · $356.3KNIH RePORTER 1R44HL170936-01A1 · fetched Nov 12, 2026